中文版 | English
题名

How to apply ex-vivo split liver transplantation safely and feasibly: A three-step approach

作者
通讯作者Zhao, Dong
发表日期
2024-06-27
DOI
发表期刊
ISSN
1948-9366
卷号16期号:6
摘要
BACKGROUND Given the current organ shortage crisis, split liver transplantation (SLT) has emerged as a promising alternative for select end-stage liver disease patients. AIM To introduce an ex-vivo liver graft splitting approach and evaluate its safety and feasibility in SLT. METHODS A retrospective analysis was conducted on the liver transplantation data from cases performed at our center between April 1, 2022, and May 31, 2023. The study included 25 SLT cases and 81 whole liver transplantation (WLT) cases. Total ex-vivo liver splitting was employed for SLT graft procurement in three steps. Patient outcomes were determined, including liver function parameters, postoperative complications, and perioperative mortality. Group comparisons for categorical variables were performed using the chi(2)-test. RESULTS In the study, postoperative complications in the 25 SLT cases included hepatic artery thrombosis (n = 1) and pulmonary infections (n = 3), with no perioperative mortality. In contrast, among the 81 patients who underwent WLT, complications included perioperative mortality (n = 1), postoperative pulmonary infections (n = 8), abdominal infection (n = 1), hepatic artery thromboses (n = 3), portal vein thrombosis (n = 1), and intra-abdominal bleeding (n = 5). Comparative analysis demonstrated significant differences in alanine aminotransferase (176.0 vs 73.5, P = 0.000) and aspartate aminotransferase (AST) (42.0 vs 29.0, P = 0.004) at 1 wk postoperatively, and in total bilirubin (11.8 vs 20.8, P = 0.003) and AST (41.5 vs 26.0, P = 0.014) at 2 wk postoperatively. However, the overall incidence of complications was comparable between the two groups (P > 0.05). CONCLUSION Our findings suggest that the total ex-vivo liver graft splitting technique is a safe and feasible approach, especially under the expertise of an experienced transplant center. The approach developed by our center can serve as a valuable reference for other transplantation centers.
关键词
相关链接[来源记录]
收录类别
语种
英语
学校署名
第一 ; 通讯
资助项目
Shenzhen Science and Technology Research and Development Fund[JCYJ20220530163011026]
WOS研究方向
Gastroenterology & Hepatology ; Surgery
WOS类目
Gastroenterology & Hepatology ; Surgery
WOS记录号
WOS:001267244800018
出版者
来源库
Web of Science
引用统计
成果类型期刊论文
条目标识符http://sustech.caswiz.com/handle/2SGJ60CL/789950
专题南方科技大学医学院
南方科技大学第一附属医院
南方科技大学第二附属医院
作者单位
1.Southern Univ Sci & Technol, Shenzhen Peoples Hosp 3, Affiliated Hosp 2, Dept Liver Surg,Sch Med, 29 Bulan Rd, Shenzhen 518112, Guangdong, Peoples R China
2.Southern Univ Sci & Technol, Shenzhen Peoples Hosp 3, Affiliated Hosp 2, Organ Transplantat Ctr,Sch Med, 29 Bulan Rd, Shenzhen 518112, Guangdong, Peoples R China
3.Southern Univ Sci & Technol, Shenzhen Peoples Hosp 3, Affiliated Hosp 2, Dept Organ Procurement Org,Sch Med, Shenzhen 518112, Guangdong, Peoples R China
第一作者单位南方科技大学医学院;  南方科技大学第二附属医院;  南方科技大学第一附属医院
通讯作者单位南方科技大学医学院;  南方科技大学第二附属医院;  南方科技大学第一附属医院
第一作者的第一单位南方科技大学医学院;  南方科技大学第二附属医院;  南方科技大学第一附属医院
推荐引用方式
GB/T 7714
Zhao, Dong,Xie, Qiu-Hua,Fang, Tai-Shi,et al. How to apply ex-vivo split liver transplantation safely and feasibly: A three-step approach[J]. WORLD JOURNAL OF GASTROINTESTINAL SURGERY,2024,16(6).
APA
Zhao, Dong.,Xie, Qiu-Hua.,Fang, Tai-Shi.,Zhang, Kang-Jun.,Tang, Jian-Xin.,...&Xie, Wen-Gui.(2024).How to apply ex-vivo split liver transplantation safely and feasibly: A three-step approach.WORLD JOURNAL OF GASTROINTESTINAL SURGERY,16(6).
MLA
Zhao, Dong,et al."How to apply ex-vivo split liver transplantation safely and feasibly: A three-step approach".WORLD JOURNAL OF GASTROINTESTINAL SURGERY 16.6(2024).
条目包含的文件
条目无相关文件。
个性服务
原文链接
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
导出为Excel格式
导出为Csv格式
Altmetrics Score
谷歌学术
谷歌学术中相似的文章
[Zhao, Dong]的文章
[Xie, Qiu-Hua]的文章
[Fang, Tai-Shi]的文章
百度学术
百度学术中相似的文章
[Zhao, Dong]的文章
[Xie, Qiu-Hua]的文章
[Fang, Tai-Shi]的文章
必应学术
必应学术中相似的文章
[Zhao, Dong]的文章
[Xie, Qiu-Hua]的文章
[Fang, Tai-Shi]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
[发表评论/异议/意见]
暂无评论

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。